(Education/Training/Seminars) TOPIC: "Rituximab Mediates Shaving of CD20 in Chronic Lymphocytic Leukemia: The Cutting Edge of Antigenic Modulation..."

• Date/Time: 05-13-2008 10:30am
• Location: Rm 120 Hollings Cancer Center
Contact:
• Rebecca Truesdell (792-4447) truesdrc@musc.edu

Message:

The Hollings Cancer Center Immunology and Immunotherapy Program is pleased to present a seminar by:

Ronald P. Taylor, Ph.D.
Professor of Biochemistry and Molecular Genetics
University of Virginia School of Medicine
Charlottesville, VA

"Rituximab Mediates Shaving of CD20 in Chronic Lymphocytic Leukemia: The Cutting Edge of Antigenic Modulation. Interpretations and General Implications With Respect to the Immunotherapy of Cancer"

Tuesday, May 13, 2008
10:30am - 11:30am Rm 120 HCC

This seminar is open to all interested faculty, postdoctoral fellows, residents and students.